Future Virology. 2010;5(4):469-479. Crimean–Congo hemorrhagic fever virus (CCHFV) internalization is clathrin and pH dependent. The CCHFV replication cycle is dependent on actin and microtubule ...

Diagonal Therapeutics Inc.’s DIAG-723 has been awarded orphan drug designation by the FDA for the treatment of hereditary hemorrhagic telangiectasia (HHT). Additionally, the EMA has provided a ...

Background: Endovascular thrombectomy has changed the management of ischemic stroke. The reperfusion can however lead to a hemorrhagic transformation (HT). Decompressive craniectomy (DC) is a surgical ...

FDA Delays Decision On KalVista's Sebetralstat NDA For Hereditary Angioedema June 13, 2025 — 11:55 pm EDT Written by RTTNews.com for RTTNews -> ...

Key teaching points highlighted in this case include hereditary hemorrhagic telangiectasia (HHT) sign/symptom recognition, standard-of-care diagnostic workup, ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it will not meet the PDUFA goal date for the New Drug ...

Hereditary haemorrhagic telangiectasia (HHT) is diagnosed clinically by the Curaçao Criteria of spontaneous recurrent nosebleeds, mucocutaneous telangiectasia at characteristic sites, visceral ...

Anemia is associated with poor outcomes and hemorrhagic expansion. 73,74 Thrombocytopenia is associated with increased mortality. 75 Acute kidney injury and hyperglycemia are associated with worse ...

For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have been no FDA-approved (or other) treatments to slow or stop vision loss.

For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have been no FDA-approved (or other) treatments to slow or stop vision loss.